Eliane Markowitz - Bio View External Director

BIOV Stock  ILS 29.00  0.70  2.36%   

Director

Dr. Eliane Markowitz was appointed External Director at BioView Ltd effective June 1, 2015 since 2015.
Age 50
Tenure 9 years
Professional MarksPh.D
Phone972 73 227 1025
Webhttps://www.bioview.com
Markowitz work experience includes the following roles: Director at Teva Medical from 2014, Chief Executive Officer at Abbott Diagnostics between 2010 and 2014 and Vice President at Medison between 2005 and 2010. She holds a Doctorate of Science degree in Animal Science.

Bio View Management Efficiency

Bio View's management efficiency ratios could be used to measure how well Bio View manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2.57 M in total debt with debt to equity ratio (D/E) of 11.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Bio-View has a current ratio of 2.1, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Bio View until it has trouble settling it off, either with new capital or with free cash flow. So, Bio View's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bio-View sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bio to invest in growth at high rates of return. When we think about Bio View's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Rami GuttermanTeuza A Fairchild
72
Or ElovitchB Communications
42
Pnina ShataRapac Communication Infrastruct
33
Imick LeviHiron Trade Investments Industr
57
Hayim CohenRapac Communication Infrastruct
59
Orly FelnerHayardenyRapac Communication Infrastruct
44
Yigal BermanRapac Communication Infrastruct
68
Uzi VardyZerHiron Trade Investments Industr
79
Benny GabbayB Communications
49
Sharon AvidarB Communications
37
Yehoshua GleitmanTeuza A Fairchild
68
Amir MakovRapac Communication Infrastruct
78
Tal NachlieliTeuza A Fairchild
55
Imik LeviHiron Trade Investments Industr
62
Moshe RosenthalB Communications
48
Bari ZeevHiron Trade Investments Industr
60
Gil KerbsTeuza A Fairchild
35
Anat WinnerB Communications
55
Binyamin GabbayB Communications
53
David FuchsTeuza A Fairchild
63
Niv AhituvRapac Communication Infrastruct
71
BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. BIO VIEW is traded on Tel Aviv Stock Exchange in Israel. Bio View (BIOV) is traded on Tel Aviv Stock Exchange in Israel and employs 35 people.

Management Performance

Bio-View Leadership Team

Elected by the shareholders, the Bio View's board of directors comprises two types of representatives: Bio View inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bio. The board's role is to monitor Bio View's management team and ensure that shareholders' interests are well served. Bio View's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bio View's outside directors are responsible for providing unbiased perspectives on the board's policies.
Elad Kfir, Vice President of Marketing
Eliane Markowitz, External Director
Yuval Harari, Co-CEO, Director
Emmanuel Gill, Chairman of the Board
David Kutas, CEO of BioView Inc - USA and President of BioView Inc - USA
Yacha Sutton, Director
Marina Wolfson, CFO
Alan Schwebel, CEO and Pres
Jackie RosenblumGoren, External Director
Yulia CPA, Chief Officer
Inbal Hillel, Vice President - Operations
Lior Shav, Director
Yuval MSc, Ex VP
Eliyahu AyalonLanciano, External Director
Warren Esanu, Director

Bio Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bio View a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Bio View

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio View position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio View will appreciate offsetting losses from the drop in the long position's value.

Moving against Bio Stock

  0.49JBNK JerusalemPairCorr
  0.41MTDS Meitav Dash InvestmentsPairCorr
The ability to find closely correlated positions to Bio View could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio View when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio View - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio View to buy it.
The correlation of Bio View is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio View moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio-View moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio View can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio View. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Bio Stock analysis

When running Bio View's price analysis, check to measure Bio View's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio View is operating at the current time. Most of Bio View's value examination focuses on studying past and present price action to predict the probability of Bio View's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio View's price. Additionally, you may evaluate how the addition of Bio View to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Please note, there is a significant difference between Bio View's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio View is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio View's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.